BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31000788)

  • 1. New insights into the ORF2 capsid protein, a key player of the hepatitis E virus lifecycle.
    Ankavay M; Montpellier C; Sayed IM; Saliou JM; Wychowski C; Saas L; Duvet S; Aliouat-Denis CM; Farhat R; de Masson d'Autume V; Meuleman P; Dubuisson J; Cocquerel L
    Sci Rep; 2019 Apr; 9(1):6243. PubMed ID: 31000788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.
    Montpellier C; Wychowski C; Sayed IM; Meunier JC; Saliou JM; Ankavay M; Bull A; Pillez A; Abravanel F; Helle F; Brochot E; Drobecq H; Farhat R; Aliouat-Denis CM; Haddad JG; Izopet J; Meuleman P; Goffard A; Dubuisson J; Cocquerel L
    Gastroenterology; 2018 Jan; 154(1):211-223.e8. PubMed ID: 28958858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Arginine-Rich Motif in the ORF2 capsid protein regulates the hepatitis E virus lifecycle and interactions with the host cell.
    Hervouet K; Ferrié M; Ankavay M; Montpellier C; Camuzet C; Alexandre V; Dembélé A; Lecoeur C; Foe AT; Bouquet P; Hot D; Vausselin T; Saliou JM; Salomé-Desnoulez S; Vandeputte A; Marsollier L; Brodin P; Dreux M; Rouillé Y; Dubuisson J; Aliouat-Denis CM; Cocquerel L
    PLoS Pathog; 2022 Aug; 18(8):e1010798. PubMed ID: 36007070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocytic recycling compartment serves as a viral factory for hepatitis E virus.
    Bentaleb C; Hervouet K; Montpellier C; Camuzet C; Ferrié M; Burlaud-Gaillard J; Bressanelli S; Metzger K; Werkmeister E; Ankavay M; Janampa NL; Marlet J; Roux J; Deffaud C; Goffard A; Rouillé Y; Dubuisson J; Roingeard P; Aliouat-Denis CM; Cocquerel L
    Cell Mol Life Sci; 2022 Dec; 79(12):615. PubMed ID: 36460928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.
    Schofield DJ; Glamann J; Emerson SU; Purcell RH
    J Virol; 2000 Jun; 74(12):5548-55. PubMed ID: 10823861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservation and variation of the hepatitis E virus ORF2 capsid protein.
    Zhang S; Qu C; Wang Y; Wang W; Ma Z; Peppelenbosch MP; Pan Q
    Gene; 2018 Oct; 675():157-164. PubMed ID: 30180962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2.
    Tyagi S; Korkaya H; Zafrullah M; Jameel S; Lal SK
    J Biol Chem; 2002 Jun; 277(25):22759-67. PubMed ID: 11934888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and epitope mapping of monoclonal antibodies raised against rat hepatitis E virus capsid protein: An evaluation of their neutralizing activity in a cell culture system.
    Kobayashi T; Takahashi M; Tanggis ; Mulyanto ; Jirintai S; Nagashima S; Nishizawa T; Okamoto H
    J Virol Methods; 2016 Jul; 233():78-88. PubMed ID: 26992654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection.
    Yin X; Ying D; Lhomme S; Tang Z; Walker CM; Xia N; Zheng Z; Feng Z
    Proc Natl Acad Sci U S A; 2018 May; 115(18):4773-4778. PubMed ID: 29669922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein.
    Zafrullah M; Ozdener MH; Kumar R; Panda SK; Jameel S
    J Virol; 1999 May; 73(5):4074-82. PubMed ID: 10196303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the C-terminal cysteines in virus-like particle formation and oligomerization of the hepatitis E virus ORF2 truncated proteins.
    Liu Z; Behloul N; Baha S; Wei W; Tao W; Zhang T; Li W; Shi R; Meng J
    Virology; 2020 May; 544():1-11. PubMed ID: 32174509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.
    Capelli N; Marion O; Dubois M; Allart S; Bertrand-Michel J; Lhomme S; Abravanel F; Izopet J; Chapuy-Regaud S
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function.
    Meister TL; Brüggemann Y; Nocke MK; Ulrich RG; Schuhenn J; Sutter K; Gömer A; Bader V; Winklhofer KF; Broering R; Verhoye L; Meuleman P; Vondran FWR; Camuzet C; Cocquerel L; Todt D; Steinmann E
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2202653119. PubMed ID: 35969792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.
    Huang WJ; Zhang HY; Harrison TJ; Lan HY; Huang GY; Wang YC
    Arch Virol; 2009; 154(3):481-8. PubMed ID: 19240977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic identification of hepatitis E virus ORF2 interactome reveals that TMEM134 engages in ORF2-mediated NF-κB pathway.
    Tian Y; Huang W; Yang J; Wen Z; Geng Y; Zhao C; Zhang H; Wang Y
    Virus Res; 2017 Jan; 228():102-108. PubMed ID: 27899274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
    Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigencity identification of recombinant hepatitis E virus ORF2 protein expressed in Pichia pastoris].
    Tong YP; Bi SL; Lu J; Jiang YZ; Zhan MY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):258-61. PubMed ID: 15340572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of B-cell epitopes in the capsid protein of avian hepatitis E virus (avian HEV) that are common to human and swine HEVs or unique to avian HEV.
    Guo H; Zhou EM; Sun ZF; Meng XJ; Halbur PG
    J Gen Virol; 2006 Jan; 87(Pt 1):217-223. PubMed ID: 16361434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4.
    Zhou YH; Purcell RH; Emerson SU
    Vaccine; 2004 Jun; 22(20):2578-85. PubMed ID: 15193383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity.
    Chen Z; Guo S; Li G; Ying D; Wen G; Fang M; Wang Y; Tang Z; Zheng Z; Xia N
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.